Fundraising Fox

Kernal Biologics

YC S20 ↗

Boston, US · Founded 2016 · Delaware corporation · 20 employees · 7 known investors

kernalbio.com ↗

Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesArtificial IntelligenceGenomicsin /kernal-biologics-inc./@kernalbioycombinator.com ↗
Kernal Biologics website preview

Founders & leadership· Y Combinator alumni (S20)

YEYusuf Erkul
Yusuf Erkulin𝕏Founder
JOJeff Ozdemir
Jeff OzdemirinFounder
BYBurak Yilmaz
Burak YilmazinFounder
BYBurak YILMAZ
Burak YILMAZinFounder
CM
Catherine MoroskiExecutive Officer, Director
OY
Oguzhan YilmasDirector

Investors · 7

Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
FoundersX VenturesSilicon Valley
HOF CapitalNew York · $25K – $15M
Hummingbird VenturesBelgium · $500K – $10M
SAV (Scale Asia Ventures)Palo Alto
Y CombinatorSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements
▶$20.1MraisedFeb 2022 · 53 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yusuf ErkulExecutive Officer, Director
  • Burak YilmazExecutive Officer, Director
Offering amount
$25.5M
Amount sold
$20.1M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Burak YilmazExecutive Officer
  • Yusuf ErkulExecutive Officer, Director
  • Oguzhan YilmazDirector
Offering amount
$1M
Amount sold
$500K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedSep 2016 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Yusuf ErkulExecutive Officer, Director
  • Catherine MoroskiExecutive Officer, Director
  • Oguzhan YilmasDirector
Offering amount
$350K
Amount sold
$350K
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news